ArticleJournal of surgical case reports2026
Single-stage minimally invasive resection of synchronous left atrial myxoma and pulmonary atypical carcinoid: case report.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synchronous primary cardiac and pulmonary tumors are rare, presenting complex therapeutic challenges regarding surgical sequencing and perioperative risk. A 52-year-old man with atrial fibrillation was incidentally diagnosed with a left atrial myxoma and a suspicious left upper lobe hilar mass. Following multidisciplinary evaluation, a single-stage minimally invasive approach was performed. The procedure involved a right mini-thoracotomy for atrial myxoma resection under cardiopulmonary bypass, followed immediately by video-assisted thoracoscopic left upper lobectomy with systematic lymph node dissection. Pathology confirmed atrial myxoma and stage IB (pT2aN0M0) pulmonary atypical carcinoid. The postoperative course was uneventful; the patient remains disease-free at 36 months. In selected patients, simultaneous minimally invasive cardiothoracic resection is feasible and effective. This integrated strategy addresses competing risks-such as systemic embolization and oncologic progression-in a single setting, supporting a risk-adapted alternative to traditional staged approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.